A Pharmacokinetic Model for Tenidap in Normal Volunteers and Rheumatoid Arthritis Patients
Authors:
- 1 October 1999
- journal article
- clinical trial
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (10) , 1608-1615
Abstract
Purpose. To develop a pharmacokinetic model for tenidap and to identify important relationships between the pharmacokinetic parameters and available covariates. Methods. Plasma concentration data...Keywords
This publication has 8 references indexed in Scilit:
- Tenidap in rheumatoid arthritis a 24‐week double‐blind comparison with hydroxychloroquine‐plus‐piroxicam, and piroxicam aloneArthritis & Rheumatism, 1995
- The pharmacokinetics of tenidap sodium: introduction.British Journal of Clinical Pharmacology, 1995
- Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.British Journal of Clinical Pharmacology, 1995
- The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.British Journal of Clinical Pharmacology, 1995
- Clinical Pharmacology and Modification of Autoimmunity and Inflammation in Rheumatoid DiseaseDrugs, 1994
- The estimation of population pharmacokinetic parameters using an EM algorithmComputer Methods and Programs in Biomedicine, 1993
- Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometryJournal of Mass Spectrometry, 1992
- The use of Weibull distribution to describe thein vivo absorption kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1987